Richey JM, Woolcott O
After the initial 4-week lead-in, the dose increases to 0.5 mg weekly
Better metabolic health markers typically emerge within the first few months of combined medication and lifestyle intervention
While Ozempic and other prescription-based semaglutide medications are authorized in Canada to treat Type 2 diabetes and cardiovascular diseases, Wegovy is known to be approved for prescription for weight loss, according to the Canadian Medical Association
consistent effort is rewarded
Additional Benefits: This liquid can address multiple obesity-related complications, such as cardiovascular disease, type 2 diabetes, arthritis, high obesity/hypertension, fatty liver, liver function recovery, brain fog and memory decline, as well as women's health issues including hormonal imbalances, menopause-related symptoms, and vaginal problems such as itching and odor